🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT06707909
Recruiting Phase 4

The Local Effect of Vitamin K2 on Bone Remodeling in Socket Preservation

NCT06707909 · tracked via the Priya Life Science Egypt tracker
Phase
Phase 4
Started
2025-02-15
Last updated
2025-02-05

Condition(s) studied

Socket Preservation

Investigational drug(s) / intervention(s)

Menaquinone

Menaquinone: the socket will be filled with crushed capsule of vitamin k2 menaquinone in study group

Study summary

This study is a randomized controlled trial comparing the effects of socket grafting with crushed vitamin K2 (menaquinone)capsules versus no grafting on bone density and socket dimensions following tooth extraction. Patients are randomly assigned to one of two groups:

Study Group (Group I): Patients receive socket grafting with crushed vitamin K2 (menaquinone) capsules. The socket is covered with an absorbent sponge, and non-resorbable sutures are placed to stabilize the graft material and achieve soft tissue stability.

Control Group (Group II): Patients undergo socket healing without grafting. The socket is covered with an absorbent sponge, and non-resorbable sutures are placed over it.

Outcome measures include bone socket dimensions evaluated immediately after extraction with graft material, as well as assessment after 4 months using cone beam computed tomography (CBCT) radiographs. Additionally, core biopsies are taken at the time of implant placement.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria:• Age \> 18 years without other age or gender restrictions. * Patients requiring extraction of mandibular single-rooted teeth. Exclusion Criteria: * • Patients with systemic conditions affecting bone metabolism. * Allergies or sensitivities to hydroxyapatite or Vitamin K2 * Untreated or residual periodontal disease; * Uncontrolled diabetes (HbA1c \> 7.5%); * Head and/or neck radiotherapy * Immunosuppressive therapy * Pregnant or nursing * Substance abuse * Treated or under treatment with intravenous amino-bisphosphonates * Patients participating in other studies, if the present protocol could not be properly followed.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cairo Cairo Cairo Governorate Recruiting

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06707909 on ClinicalTrials.gov ↗ ← All trials in Egypt